Related Experiment Video
Updated: Jan 20, 2026
04:54
Author Spotlight: A Stable Phantom Material for Optical and Acoustic Imaging
Published on: June 16, 2023
3.7K
Sn2Ga2S5: A Type of IR Nonlinear-Optical Material
Zhi-Hui Shi1, Yang Chi1, Zong-Dong Sun1
1School of Chemistry and Chemical Engineering , Yangzhou University , Yangzhou , Jiangsu 225002 , P. R. China.
Inorganic Chemistry
|August 29, 2019
Summary
Researchers discovered Sn2Ga2S5, a novel nonlinear-optical (NLO) material with significant NLO activity and a high laser-induced damage threshold. This finding addresses the need for advanced NLO materials in the infrared region.
Area of Science:
- Materials Science
- Solid-State Chemistry
- Optoelectronics
Background:
- The development of advanced nonlinear-optical (NLO) materials is crucial for infrared (IR) applications.
- Existing NLO materials often exhibit limitations in performance or applicability within the IR spectrum.
Purpose of the Study:
- To identify and characterize novel NLO materials with enhanced properties for IR applications.
- To investigate the potential of the MII2MIII2Q5 family for NLO activity.
Main Methods:
- Synthesis and crystallographic analysis of Sn2Ga2S5 (1).
- Experimental measurement of NLO properties, including NLO coefficients and laser-induced damage threshold (LIDT).
- Theoretical calculations to understand the origin of NLO effects.
Main Results:
- Sn2Ga2S5 (1) was synthesized and confirmed to crystallize in the orthorhombic Pna21 space group.
- Compound 1 exhibits significant NLO activity, with a maximum NLO response approximately 1.6 times that of AgGaS2.
- Compound 1 demonstrates a high laser-induced damage threshold, 9.7 times that of AGS.
- This is the first reported NLO-active compound within the MII2MIII2Q5 family.
Conclusions:
- Sn2Ga2S5 (1) is a promising new material for nonlinear-optical applications, particularly in the IR region.
- The discovery expands the known family of NLO-active compounds and provides a new platform for material design.
Related Concept Videos
01:22Nonlinear Pharmacokinetics: Causes of Nonlinearity
712
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
712
01:19Nonlinear Pharmacokinetics: Overview
1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K
01:18Nonlinear Pharmacokinetics: Michaelis-Menten Equation
1.0K
The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
1.0K
01:27Nonlinear Pharmacokinetics: Role of Transporters
284
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
284
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
599
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
599
01:19Members Made of Elastoplastic Material
376
The behavior of elastoplastic materials under bending stresses, particularly in structural members with rectangular cross-sections, is crucial for predicting material responses and understanding failure modes. Initially, when a bending moment is applied, the stress distribution across the section follows Hooke's Law and is linear and elastic. This distribution means the stress increases from the neutral axis to the maximum at the outer fibers, up to the elastic limit.
As the bending moment...
As the bending moment...
376